Jessica Skarzynski

While radiation therapy may be a common alternative for inoperable hepatocellular carcinoma, two new studies suggest that proton radiation therapy may offer the same benefits as the more traditionally used photon radiation therapy, with less toxicity.

On this week’s episode of the CURE Talks Cancer podcast, we talk with Grammy-winning songwriter and vocal producer Kuk Harrell about what it’s like to be “on the other side” of his prostate cancer diagnosis, and how he’s using his platform to shine a light on the disease.

November is Stomach Cancer Awareness Month. Here's a round up of the latest news and updates in this disease space.

While resistance can often make it a challenge to treat mantle cell lymphoma, therapies have come a long way in recent years thanks to the emergence of personalized treatment and the use of BTK inhibitors, according to one expert.

Researchers are expanding a clinical trial to include more patients with mantle cell lymphoma after some patients given the combination of medications under investigation showed no signs of cancer after treatment.

For National Family Caregivers Month, here’s a round-up of the latest news and updates that focus on the friends and family members that take up the role of caregiver when their loved ones need them most.

Here’s a sneak peek at what’s inside our Heal Fall 2019 issue.

We asked our readers, what is the most important lesson cancer has taught you?

Former NHL referee Kerry Fraser opens up about living with an incurable cancer that he refuses to let sideline him.

For Lung Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

The saying goes that hindsight is 20/20, but often, individuals who have dealt with cancer express that they would have plenty to say if they could go back and talk to themselves before cancer entered the picture.

Here’s a look at what’s inside our 2019 Breast Cancer special issue.

The therapy is approved to decrease the incidence of infection due to febrile neutropenia in patients receiving myelosuppressive anti-cancer therapy.

For Pancreatic Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

The field of kidney cancer treatment could soon be expanding thanks to the inclusion of PARP inhibitors, vaccination-based strategies and emerging therapies such as Fotivda (tivozanib), according to research presented at the 2019 Kidney Cancer Research Summit.

Here are the top five CURE® stories for October 2019.

Here’s a sneak peek at what’s inside our Fall 2019 issue.

CURE® asked its readers for their thoughts on “Pinktober,” which ran the gamut of emotions.

The Food and Drug Administration has approved Zejula for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer that have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency-positive status.

We've got a sneak peek at what’s inside CURE®'s 2019 Genitourinary Cancers special issue.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Thursday, October 31, at 1 p.m. EST, when we plan on discussing coping with cancer.

Recent changes to the National Comprehensive Cancer Network (NCCN) guidelines around prostate cancer have updated the indications for genetic testing and have opened up a broader discussion on how it can be used to improve prostate cancer detection and treatment, according to Dr. James Mohler.

For Liver Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

For Metastatic Breast Cancer Awareness Day on October 13th, 2019, here’s a round-up of fast facts and the latest news and updates in this disease space.

Reading, writing, art, music... CURE recently asked its social media audience to share the creative outlets and activities that have helped them on their cancer journey. Here are some of their responses – in the hopes of helping others find a new hobby of their own.

Here are the top five CURE stories for September 2019.

Readers of CURE share the ways that cancer has changed their lives.

For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

Here’s a look at what’s inside our 2019 Hematology special issue.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Thursday, September 26, at 1 p.m. EST, when we plan on discussing living with cancer.